ADM Tronics Unlimited Inc.
224 S. Pegasus Avenue
Northvale, New Jersey 07647
Founded in November, 1969 ADMT initially started as an R&D company developing and selling non-toxic chemicals to various industries, particularly the food and medical packaging industries. Subsequently ADMT began producing water-based adhesives, coatings and additives, in addition to its environmentally safe chemical business. However, due to the skill and creativity of its' founder Dr. Alphonso DiMino, an internationally recognized inventor, ADMT entered into the medical device industry, which became the company's core business. After having developed a number of proprietary, patented therapeutic electronic medical devices, ADMT then progressed to become an FDA-registered medical device manufacturing facility producing its own Class I, II and III medical devices. The ADMT products were well received in both the U.S. and foreign markets, enabling ADMT to build a state of the art, self-sufficient technological infrastructure with a staff of multi-disciplinary medical device engineers, researchers and technologists.
The Affordable Care Act, commonly referred to as Obamacare, had a devastating effect on the Medical Device industry, primarily due to a new excise tax and reduced reimbursements for various medical procedures. In turn, this had a severe impact on ADMT's business plans and results in late 2012 and early 2013. In response, in early 2013 ADMT reconstructed its business model and instituted a new plan of action by offering its leading-edge electronic medical device engineering, regulatory and manufacturing expertise to other medical device companies in the United States and Europe.. This had a significant positive effect, resulting in 10 consecutive quarters of increased revenues and profits. This change in business strategy allowed ADMT to continue to support its own proprietary medical device technologies which the management plans to introduce to the market upon completion.
COMPANY BUSINESS SUMMARY
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, design, develop and manufacture the final product and ultimately commercialize it.
Proprietary Electronic Medical Devices - Sonotron --- Aurex---Alvio (joint venture with QOL)
Eco-Friendly, Safe, Water-Based Formulations
Original Equipment Manufacturing --- utilizing advanced technology infrastructure, such as 3-D solid prototyping and precision instrumentation
Provider of a Full Range of Electronic Medical Device Engineering, Design and Regulatory Services
• 10 consecutive Quarters of increased revenues and profits
• Proprietary Medical Devices to be launched upon completion
• Organic Growth---no equity or debt offerings in over 10 years.
• State of the Art Facility. Savvy Research, Design and Engineering Team
• Responsive Dedicated Management
Fiscal Year Pay
|Andre DiMino||President and CEO||$154,000||View Biography|
|Timothy Gilmartin||VP Production||N/A|
|Matthew Drummer||Chief Science Officer||N/A|
|Lindley Curameng||VP Regulatory||N/A|
SHARE RELATED INFORMATION
|52 Week High:||.23 on 2/13/17||Total Shares Outstanding:||67,578,502|
|52 Week Low:||.145 on 10/20/16||Public Float:||39,500,000|
|All time High:||$1.50 on 11/10/98||Earnings Per Share:||.003|
|All time Low:||.01 on 8/1/10||Book Value:||.05|
View Historical Stock Prices & Volume for this company
FUNDAMENTAL INVESTMENT HIGHLIGHTS
All numbers in Thousands
Prior Fiscal Yr
|Pre-Tax Earnings (Losses)||$1,137||$261||($43)|
View all Filings for this company
NEWSPAPER / MAGAZINE ARTICLES / RESEARCH REPORTS
Click here to go Back